Enanta Pharma (ENTA) Tops Q3 EPS by 4c. Revs Miss

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/1/2026

1. INTC
2. AMZN
3. RDDT
4. COIN
5. PINS
6. FSLR
7. SYK
8. GILD
9. SBUX
10. SNDK

Go back to Enanta Pharma (ENTA) Tops Q3 EPS by 4c. Revs Miss

Enanta Pharmaceuticals (ENTA) PT Raised to $38 at JPMorgan

August 8, 2017 8:45 AM EDT

JPMorgan raised its price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $38.00 (from $32.00) while maintaining a Overweight rating.

... More

Enanta Pharmaceuticals (ENTA) PT Raised to $36 at Baird; Remains Sidelined

August 8, 2017 7:19 AM EDT

Baird raised its price target on Enanta Pharmaceuticals (NASDAQ: ENTA) to $36.00 (from $27.00) while maintaining a Neutral rating following the company's 3Q. AbbVie's reported sales of $225M for Viekira were largely in line with estimates. Enanta earned $7.5M in royalty revenue on these sales, versus... More